Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Dec 1;154(12):1394-1400.
doi: 10.1001/jamadermatol.2018.3301.

Association of Caffeine Intake and Caffeinated Coffee Consumption With Risk of Incident Rosacea in Women

Affiliations
Multicenter Study

Association of Caffeine Intake and Caffeinated Coffee Consumption With Risk of Incident Rosacea in Women

Suyun Li et al. JAMA Dermatol. .

Abstract

Importance: Caffeine is known to decrease vasodilation and have immunosuppressant effects, which may potentially decrease the risk of rosacea. However, the heat from coffee may be a trigger for rosacea flares. The relationship between the risk of rosacea and caffeine intake, including coffee consumption, is poorly understood.

Objective: To determine the association between the risk of incident rosacea and caffeine intake, including coffee consumption.

Design, setting, and participants: This cohort study included 82 737 women in the Nurses' Health Study II (NHS II), a prospective cohort established in 1989, with follow-up conducted biennially between 1991 and 2005. All analysis took place between June 2017 and June 2018.

Exposures: Data on coffee, tea, soda, and chocolate consumption were collected every 4 years during follow-up.

Main outcomes and measures: Information on history of clinician-diagnosed rosacea and year of diagnosis was collected in 2005.

Results: A total of 82 737 women responded to the question regarding a diagnosis of rosacea in 2005 in NHS II and were included in the final analysis (mean [SD] age at study entry, 50.5 [4.6] years). During 1 120 051 person-years of follow-up, we identified 4945 incident cases of rosacea. After adjustment for other risk factors, we found an inverse association between increased caffeine intake and risk of rosacea (hazard ratio for the highest quintile of caffeine intake vs the lowest, 0.76; 95% CI, 0.69-0.84; P < .001 for trend). A significant inverse association with risk of rosacea was also observed for caffeinated coffee consumption (HR, 0.77 for those who consumed ≥4 servings/d vs those who consumed <1/mo; 95% CI, 0.69-0.87; P < .001 for trend), but not for decaffeinated coffee (HR, 0.80; 95% CI, 0.56-1.14; P = .39 for trend). Further analyses found that increased caffeine intake from foods other than coffee (tea, soda, and chocolate) was not significantly associated with decreased risk of rosacea.

Conclusions and relevance: Increased caffeine intake from coffee was inversely associated with the risk of incident rosacea. Our findings do not support limiting caffeine intake as a means to prevent rosacea. Further studies are required to explain the mechanisms of action of these associations, to replicate our findings in other populations, and to explore the relationship of caffeine with different rosacea subtypes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: Dr Drucker has served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Canadian Agency for Drugs and Technologies in Health, Sanofi, RTI Health Solutions, and Eczema Society of Canada. He has received honoraria from Astellas Canada, Prime Inc, Spire Learning, CME Outfitters, and Eczema Society of Canada. Dr Qureshi is Consultant for Abbvie, Amgen, Centers for Disease Control and Prevention, Janssen, Merck, Novartis, and Pfizer. No other disclosures are reported.

Comment in

References

    1. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6)(suppl 1):S15-S26. doi:10.1016/j.jaad.2013.04.045 - DOI - PubMed
    1. Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea—global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011;25(2):188-200. doi:10.1111/j.1468-3083.2010.03751.x - DOI - PubMed
    1. Mikkelsen CS, Holmgren HR, Kjellman P, et al. . Rosacea: a clinical review. Dermatol Reports. 2016;8(1):6387. doi:10.4081/dr.2016.6387 - DOI - PMC - PubMed
    1. Vieira AC, Höfling-Lima AL, Mannis MJ. Ocular rosacea—a review. Arq Bras Oftalmol. 2012;75(5):363-369. doi:10.1590/S0004-27492012000500016 - DOI - PubMed
    1. Ferahbas A, Utas S, Mistik S, Uksal U, Peker D. Rosacea fulminans in pregnancy: case report and review of the literature. Am J Clin Dermatol. 2006;7(2):141-144. doi:10.2165/00128071-200607020-00007 - DOI - PubMed

Publication types